Publications by authors named "Virginia Knight"

Claim this Profile
V
Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?
Timothy Phan, Kurvi Patwala, Lara Lipton, Virginia Knight, Ahmad Aga

Curr Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival.
Stuart K Roberts, Alessia Gazzola, John Lubel, Paul Gow, Sally Bell, Virginia Knight

Scand J Gastroenterol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Thai P Hong, Paul J Gow, Michael Fink, Anouk Dev, Stuart K Roberts, Virginia Knight

Med J Aust· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.
Stephen Bloom, William Kemp, Amanda Nicoll, Stuart K Roberts, Paul Gow, Virginia Knight

J Hepatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic domain of tissue factor promotes liver fibrosis in mice.
Virginia Knight, Dinushka Lourensz, Jorge Tchongue, Jeanne Correia, Peter Tipping

World J Gastroenterol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B.
Alexander Hodge, Sarah Lim, Evan Goh, Ophelia Wong, Philip Marsh, Virginia Knight

Nutrients· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study.
Adam Doyle, Philip Marsh, Raghubinder Gill, Marcia Rodov, Waled Mohsen, Virginia Knight

Scand J Gastroenterol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
Thai P Hong, Paul Gow, Michael Fink, Anouk Dev, Stuart Roberts, Virginia Knight

Hepatology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
Ilana Gory, Michael Fink, Sally Bell, Paul Gow, Amanda Nicoll, Virginia Knight

Scand J Gastroenterol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Virginia Knight, Jorge Tchongue, Dinushka Lourensz, Peter Tipping, William Sievert

Hepatology· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When less may not be best--the challenge of individualising antiviral therapy for chronic hepatitis C infection.
Virginia Knight, William Sievert

J Gastroenterol Hepatol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis